146 related articles for article (PubMed ID: 31366479)
1. Circulating Protein Biomarkers to Differentiate Uterine Sarcomas from Leiomyomas.
Glorie N; Baert T; VAN DEN Bosch T; Coosemans AN
Anticancer Res; 2019 Aug; 39(8):3981-3989. PubMed ID: 31366479
[TBL] [Abstract][Full Text] [Related]
2. Growth differentiation factor-15 as biomarker in uterine sarcomas.
Trovik J; Salvesen HB; Cuppens T; Amant F; Staff AC
Int J Gynecol Cancer; 2014 Feb; 24(2):252-9. PubMed ID: 24401984
[TBL] [Abstract][Full Text] [Related]
3. Development of a novel and rapid measurement system for growth differentiation factor-15, progranulin, and osteopontin in uterine sarcoma.
Maeno M; Mizutani T; Tsuyoshi H; Yamada S; Ishikane S; Kawabe S; Nishimura K; Yamada M; Miyamoto K; Yoshida Y
Endocr J; 2020 Jan; 67(1):91-94. PubMed ID: 31534059
[TBL] [Abstract][Full Text] [Related]
4. Circulating Transcripts and Biomarkers in Uterine Tumors: Is There a Predictive Role?
De Bruyn C; Baert T; Van den Bosch T; Coosemans A
Curr Oncol Rep; 2020 Jan; 22(2):12. PubMed ID: 31997106
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison.
Kim HS; Han KH; Chung HH; Kim JW; Park NH; Song YS; Kang SB
Eur J Surg Oncol; 2010 Jul; 36(7):691-8. PubMed ID: 20570475
[TBL] [Abstract][Full Text] [Related]
6. A more accurate method to interpret lactate dehydrogenase (LDH) isoenzymes' results in patients with uterine masses.
Di Cello A; Borelli M; Marra ML; Franzon M; D'Alessandro P; Di Carlo C; Venturella R; Zullo F
Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():143-147. PubMed ID: 30925450
[TBL] [Abstract][Full Text] [Related]
7. Machine Learning to Differentiate T2-Weighted Hyperintense Uterine Leiomyomas from Uterine Sarcomas by Utilizing Multiparametric Magnetic Resonance Quantitative Imaging Features.
Nakagawa M; Nakaura T; Namimoto T; Iyama Y; Kidoh M; Hirata K; Nagayama Y; Yuki H; Oda S; Utsunomiya D; Yamashita Y
Acad Radiol; 2019 Oct; 26(10):1390-1399. PubMed ID: 30661978
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the predictivity of preoperative serum CA 125 in the differential diagnosis of uterine leiomyoma and uterine sarcoma in the Turkish female population.
Yilmaz N; Sahin I; Kilic S; Ozgu E; Gungor T; Bilge U
Eur J Gynaecol Oncol; 2009; 30(4):412-4. PubMed ID: 19761133
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity in needle biopsied uterine myoma-like tumors: differential diagnosis between uterine sarcomas and leiomyomas.
Tsujimura A; Kawamura N; Ichimura T; Honda K; Ishiko O; Ogita S
Int J Oncol; 2002 Feb; 20(2):361-5. PubMed ID: 11788902
[TBL] [Abstract][Full Text] [Related]
10. Assessment of MR Imaging as a Tool to Differentiate between the Major Histological Types of Uterine Sarcomas.
Sumi A; Terasaki H; Sanada S; Uchida M; Tomioka Y; Kamura T; Yano H; Abe T
Magn Reson Med Sci; 2015; 14(4):295-304. PubMed ID: 26104072
[TBL] [Abstract][Full Text] [Related]
11. Liquid Biopsy as a Tool for Differentiation of Leiomyomas and Sarcomas of Corpus Uteri.
Dvorská D; Škovierová H; Braný D; Halašová E; Danková Z
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387281
[TBL] [Abstract][Full Text] [Related]
12. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma.
Parker WH; Fu YS; Berek JS
Obstet Gynecol; 1994 Mar; 83(3):414-8. PubMed ID: 8127535
[TBL] [Abstract][Full Text] [Related]
13. Analysis of uterine corporeal mesenchymal tumors occurring after menopause.
Ishidera Y; Yoshida H; Oi Y; Katayama K; Miyagi E; Hayashi H; Shigeta H
BMC Womens Health; 2019 Jan; 19(1):13. PubMed ID: 30658711
[TBL] [Abstract][Full Text] [Related]
14. Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI.
Malek M; Rahmani M; Seyyed Ebrahimi SM; Tabibian E; Alidoosti A; Rahimifar P; Akhavan S; Gandomkar Z
Cancer Imaging; 2019 Apr; 19(1):20. PubMed ID: 30935419
[TBL] [Abstract][Full Text] [Related]
15. [Malignancy of uterine sarcoma in comparison with suspect leiomyoma. An anatomo-clinical study of 16 cases].
Socolov RV; Pricop FZ; Stratan D
Rev Fr Gynecol Obstet; 1992 Oct; 87(10):457-60. PubMed ID: 1470817
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of MRI in the differential diagnosis between uterine leiomyomas and sarcomas: A systematic review and meta-analysis.
Raffone A; Raimondo D; Neola D; Travaglino A; Giorgi M; Lazzeri L; De Laurentiis F; Carravetta C; Zupi E; Seracchioli R; Casadio P; Guida M
Int J Gynaecol Obstet; 2024 Apr; 165(1):22-33. PubMed ID: 37732472
[TBL] [Abstract][Full Text] [Related]
17. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density.
Hague S; Zhang L; Oehler MK; Manek S; MacKenzie IZ; Bicknell R; Rees MC
Clin Cancer Res; 2000 Jul; 6(7):2808-14. PubMed ID: 10914728
[TBL] [Abstract][Full Text] [Related]
18. Preliminary observations and clinical value of lipid peak in high-grade uterine sarcomas using in vivo proton MR spectroscopy.
Takeuchi M; Matsuzaki K; Harada M
Eur Radiol; 2013 Sep; 23(9):2358-63. PubMed ID: 23740024
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus.
Goto A; Takeuchi S; Sugimura K; Maruo T
Int J Gynecol Cancer; 2002; 12(4):354-61. PubMed ID: 12144683
[TBL] [Abstract][Full Text] [Related]
20. Prognostic importance of vascular endothelial growth factor and its receptors in the uterine sarcoma.
Arita S; Kikkawa F; Kajiyama H; Shibata K; Kawai M; Mizuno K; Nagasaka T; Ino K; Nomura S
Int J Gynecol Cancer; 2005; 15(2):329-36. PubMed ID: 15823121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
